Chlamydia trachomatis as a probable cofactor in human papillomavirus infection in aboriginal women from northeastern Argentina

Brazilian Journal of Infectious Diseases

Volumn 15, Issue 6, 2011, Pages 567-572

  Daniel Deluca, Gerardo ^a   Basiletti, Jorge ^b   Schelover, Eduardo ^c   Díaz Vásquez, Nicolás ^c   Mario Alonso, José ^c   Marcelo Marín, Héctor ^c   Horacio Lucero, Raúl ^c   Alejandra Picconi, María ^b  

^a UNIVERSIDAD NACIONAL DEL NORDESTE   (Argentina)

^b INSTITUTO NACIONAL DE ENFERMEDADES INFECCIOSAS   (Argentina)

^c UNIVERSIDAD NACIONAL DEL NORDESTE   (Argentina)

Author keywords

Chlamydia trachomatis; Indigenous population; Papillomavirus infections; Uterine cervical diseases

Indexed keywords

VIRUS DNA;

ABORIGINE; ADOLESCENT; ADULT; AGED; ARGENTINA; ARTICLE; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CONCURRENT INFECTION; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FEMALE; HEALTH CENTER; HIGH RISK POPULATION; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 58; HUMAN PAPILLOMAVIRUS TYPE 6; INFECTION RATE; INFECTION RISK; MAJOR CLINICAL STUDY; MASS SCREENING; PAPILLOMAVIRUS INFECTION; POLYMERASE CHAIN REACTION; PREVALENCE; RISK ASSESSMENT; SOCIAL STATUS; VULNERABLE POPULATION;

ADOLESCENT; ADULT; AGED; ARGENTINA; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; DNA, VIRAL; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; INDIANS, SOUTH AMERICAN; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; PRECANCEROUS CONDITIONS; PREGNANCY; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS; YOUNG ADULT;

EID: 84855963158     PISSN: 14138670     EISSN: 16784391     Source Type: Journal    
DOI: 10.1016/S1413-8670(11)70252-5     Document Type: Article

References (35)

1. World Health Organization. Global prevalence and incidence of selected curable sexually transmitted infections-Overview and estimates [Internet]. Geneva; 2001. Available from: http://www.who.int/hiv/pub/sti/who_hiv_aids_2001.02.pdf.
2. Stamm W.E. Chlamydia trachomatis infections of the adult. Sexually transmitted diseases 2008, 575-594. McGraw-Hill Medical, New York. K.K. Holmes, P.F. Sparling, W.E. Stamm (Eds.).
3. Stamm W.E. Chlamydia trachomatis - the persistent pathogen: Thomas Parran Award Lecture. Sex Transm Dis 2001, 28(12):684-689.
4. Smith J.S., Bosetti C., Muñoz N., et al. Chlamydia trachomatis and invasive cervical cancer: a pooled analysis of the IARC multicentric case-control study. Int J Cancer 2004, 111(3):431-439.
5. Lehtinen M, Ault KA, Lyytikainen E, et al. Chlamydia trachomatis infection and risk of cervical intraepithelial neoplasia. Sex Transm Infect [Internet]. 2011; Available from: http://www.ncbi.nlm.nih.gov/pubmed/21471141.
6. Oliveira M.L., Amorim M.M.R., Souza P.R.E., et al. Chlamydia infection in patients with and without cervical intra-epithelial lesions tested by real-time PCR vs. direct immunofluorescence. Braz J Infect Dis 2008, 12(4):324-328.
7. Silins I., Ryd W., Strand A., et al. Chlamydia trachomatis infection and persistence of human papillomavirus. Int J Cancer 2005, 116(1):110-115.
8. Smith J.S., Muñoz N., Herrero R., et al. Evidence for Chlamydia trachomatis as a human papillomavirus cofactor in the etiology of invasive cervical cancer in Brazil and the Philippines. J Infect Dis 2002, 185(3):324-331.
9. Simonetti A.C., Melo J.H., de L., de Souza P.R.E., et al. Immunological's host profile for HPV and Chlamydia trachomatis, a cervical cancer cofactor. Microbes Infect 2009, 11(4):435-442.
10. Bosch F.X., Burchell A.N., Schiffman M., et al. Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia. Vaccine 2008, 26:K1-K16.
11. Schiffman M., Castle P.E., Jeronimo J., et al. Human papillomavirus and cervical cancer. Lancet 2007, 370(9590):890-907.
12. Kjaer S.K., van den Brule A.J.C., Paull G., et al. Type specific persistence of high risk human papillomavirus (HPV) as indicator of high grade cervical squamous intraepithelial lesions in young women: population based prospective follow up study. BMJ 2002, 325(7364):572.
13. Ho G.Y., Burk R.D., Klein S., et al. Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J Natl Cancer Inst 1995, 87(18):1365-1371.
14. Almonte M., Albero G., Molano M., et al. Risk factors for human papillomavirus exposure and co-factors for cervical cancer in Latin America and the Caribbean. Vaccine 2008, 26(Suppl 11):L16-L36.
15. Drain P.K., Holmes K.K., Hughes J.P., et al. Determinants of cervical cancer rates in developing countries. Int J Cancer 2002, 100(2):199-205.
16. Arrossi S. Proyecto para el mejoramiento del Programa Nacional de Prevención de Cáncer de Cuello Uterino en Argentina. Informe final: Diagnóstico de situación del Programa Nacional y Programas Provinciales [Internet]. 1st ed. Buenos Aires: Organización Panamericana de la Salud, OPS; 2008. Available from: http://www.msal.gov.ar/cancercervico-%20uterino/pdf/pub64_ops.pdf.
17. Mahony J.B., Luinstra K.E., Sellors J.W., et al. Confirmatory polymerase chain reaction testing for Chlamydia trachomatis in firstvoid urine from asymptomatic and symptomatic men. J Clin Microbiol 1992, 30(9):2241-2245.
18. Bernard H.U., Chan S.Y., Manos M.M., et al. Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction amplification, restriction fragment length polymorphisms, nucleotide sequence, and phylogenetic algorithms. J Infect Dis 1994, 170(5):1077-1085.
19. Manos M.M., Ting Y., Wright D.K., et al. The use of polymerase chain reaction amplification for the detection of genital human papillomavirus. Cancer Cells 1989, 7:209-214.
20. Franceschi S., Smith J.S., van den Brule A., et al. Cervical infection with Chlamydia trachomatis and Neisseria gonorrhoeae in women from ten areas in four continents. A cross-sectional study. Sex Transm Dis 2007, 34(8):563-569.
21. León S.R., Konda K.A., Klausner J.D., et al. Chlamydia trachomatis infection and associated risk factors in a low-income marginalized urban population in coastal Peru. Rev Panam Salud Publica 2009, 26(1):39-45.
22. Martínez T.M.A., Reid S.I., Arias C., et al. Prevalence of cervical infection by Chlamydia trachomatis among Chilean women living in the Metropolitan Region. Rev Med Chil 2008, 136(10):1294-1300.
23. Rodrigues M.M., Fernandes Pá, Haddad J.P., et al. Frequency of Chlamydia trachomatis, Neisseria gonorrhoeae, Mycoplasma genitalium, Mycoplasma hominis and Ureaplasma species in cervical samples. J Obstet Gynaecol 2011, 31(3):237-241.
24. Santos C., Teixeira F., Vicente A., et al. Detection of Chlamydia trachomatis in endocervical smears of sexually active women in Manaus-AM, Brazil, by PCR. Braz J Infect Dis 2003, 7(2):91-95.
25. Wilson J.S., Honey E., Templeton A., et al. A systematic review of the prevalence of Chlamydia trachomatis among European women. Hum Reprod Update 2002, 8(4):385-394.
26. de Cristófano M.A., Livellara B., Galli M.A., et al. Extent of endemic Chlamydia trachomatis in the metropolitan area of Buenos Aires (Argentina). Enferm Infecc Microbiol Clin 1997, 15(3):134-139.
27. Di Bartolomeo S., Rodríguez M., Sauka D., et al. Microbiologic profile in symptomatic pregnant women's genital secretions in Gran Buenos Aires, Argentina. Enferm Infecc Microbiol Clin 2001, 19(3):99-102.
28. Golijow C.D., Abba M.C., Mourón S.A., et al. Chlamydia trachomatis and human papillomavirus infections in cervical disease in Argentine women. Gynecol Oncol 2005, 96(1):181-186.
29. de Sanjosé S., Diaz M., Castellsagué X., et al. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis 2007, 7(7):453-459.
30. Clifford G., Gallus S., Herrero R., et al. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet 2005, 366(9490):991-998.
31. Tonon S.A., Picconi M.A., Zinovich J.B., et al. Prevalence of cervical infection by human papilloma virus (HPV) in the Caucasian and Guaraní populations residing in the province of Misiones, Argentina. Rev Argent Microbiol 2003, 35(4):205-213.
32. Picconi M.A., Gronda J., Alonio L.V., et al. Human papilloma virus in Quechua women from Jujuy with high frequency of cervical cancer: viral types and HPV-16 variants. Medicina (B Aires) 2002, 62(3):209-220.
33. Matos E., Loria D., Amestoy G.M., et al. Prevalence of human papillomavirus infection among women in Concordia, Argentina: a population-based study. Sex Transm Dis 2003, 30(8):593-599.
34. Sijvarger C.C., González J.V., Prieto A., et al. Cervical infection epidemiology of human papillomavirus in Ushuaia, Argentina. Rev Argent Microbiol 2006, 38(1):19-24.
35. Verhoeven V., Baay M., Weyler J., et al. Concomitant Chlamydia trachomatis and human papilloma virus infection cannot be attributed solely to sexual behaviour. Eur J Clin Microbiol Infect Dis 2004, 23(9):735-737.